Literature DB >> 22190368

Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis.

Michael A van Es1, Helenius J Schelhaas, Paul W J van Vught, Nicola Ticozzi, Peter M Andersen, Ewout J N Groen, Claudia Schulte, Hylke M Blauw, Max Koppers, Frank P Diekstra, Katsumi Fumoto, Ashley Lyn LeClerc, Pamela Keagle, Bastiaan R Bloem, Hans Scheffer, Bart F L van Nuenen, Marka van Blitterswijk, Wouter van Rheenen, Anne-Marie Wills, Patrick P Lowe, Guo-fu Hu, Wenhao Yu, Hiroko Kishikawa, David Wu, Rebecca D Folkerth, Claudio Mariani, Stefano Goldwurm, Gianni Pezzoli, Philip Van Damme, Robin Lemmens, Caroline Dahlberg, Anna Birve, Rubén Fernández-Santiago, Stefan Waibel, Christine Klein, Markus Weber, Anneke J van der Kooi, Marianne de Visser, Dagmar Verbaan, Jacobus J van Hilten, Peter Heutink, Eric A M Hennekam, Edwin Cuppen, Daniela Berg, Robert H Brown, Vincenzo Silani, Thomas Gasser, Albert C Ludolph, Wim Robberecht, Roel A Ophoff, Jan H Veldink, R Jeroen Pasterkamp, Paul I W de Bakker, John E Landers, Bart P van de Warrenburg, Leonard H van den Berg.   

Abstract

OBJECTIVE: Several studies have suggested an increased frequency of variants in the gene encoding angiogenin (ANG) in patients with amyotrophic lateral sclerosis (ALS). Interestingly, a few ALS patients carrying ANG variants also showed signs of Parkinson disease (PD). Furthermore, relatives of ALS patients have an increased risk to develop PD, and the prevalence of concomitant motor neuron disease in PD is higher than expected based on chance occurrence. We therefore investigated whether ANG variants could predispose to both ALS and PD.
METHODS: We reviewed all previous studies on ANG in ALS and performed sequence experiments on additional samples, which allowed us to analyze data from 6,471 ALS patients and 7,668 controls from 15 centers (13 from Europe and 2 from the USA). We sequenced DNA samples from 3,146 PD patients from 6 centers (5 from Europe and 1 from the USA). Statistical analysis was performed using the variable threshold test, and the Mantel-Haenszel procedure was used to estimate odds ratios.
RESULTS: Analysis of sequence data from 17,258 individuals demonstrated a significantly higher frequency of ANG variants in both ALS and PD patients compared to control subjects (p = 9.3 × 10(-6) for ALS and p = 4.3 × 10(-5) for PD). The odds ratio for any ANG variant in patients versus controls was 9.2 for ALS and 6.7 for PD.
INTERPRETATION: The data from this multicenter study demonstrate that there is a strong association between PD, ALS, and ANG variants. ANG is a genetic link between ALS and PD.
Copyright © 2011 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22190368      PMCID: PMC5560057          DOI: 10.1002/ana.22611

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  50 in total

Review 1.  Amyotrophic lateral sclerosis.

Authors:  L P Rowland; N A Shneider
Journal:  N Engl J Med       Date:  2001-05-31       Impact factor: 91.245

2.  alpha-Synuclein locus triplication causes Parkinson's disease.

Authors:  A B Singleton; M Farrer; J Johnson; A Singleton; S Hague; J Kachergus; M Hulihan; T Peuralinna; A Dutra; R Nussbaum; S Lincoln; A Crawley; M Hanson; D Maraganore; C Adler; M R Cookson; M Muenter; M Baptista; D Miller; J Blancato; J Hardy; K Gwinn-Hardy
Journal:  Science       Date:  2003-10-31       Impact factor: 47.728

3.  Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.

Authors:  E Sidransky; M A Nalls; J O Aasly; J Aharon-Peretz; G Annesi; E R Barbosa; A Bar-Shira; D Berg; J Bras; A Brice; C-M Chen; L N Clark; C Condroyer; E V De Marco; A Dürr; M J Eblan; S Fahn; M J Farrer; H-C Fung; Z Gan-Or; T Gasser; R Gershoni-Baruch; N Giladi; A Griffith; T Gurevich; C Januario; P Kropp; A E Lang; G-J Lee-Chen; S Lesage; K Marder; I F Mata; A Mirelman; J Mitsui; I Mizuta; G Nicoletti; C Oliveira; R Ottman; A Orr-Urtreger; L V Pereira; A Quattrone; E Rogaeva; A Rolfs; H Rosenbaum; R Rozenberg; A Samii; T Samaddar; C Schulte; M Sharma; A Singleton; M Spitz; E-K Tan; N Tayebi; T Toda; A R Troiano; S Tsuji; M Wittstock; T G Wolfsberg; Y-R Wu; C P Zabetian; Y Zhao; S G Ziegler
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

4.  Progress and challenges in genome-wide association studies in humans.

Authors:  Peter Donnelly
Journal:  Nature       Date:  2008-12-11       Impact factor: 49.962

5.  VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death.

Authors:  Diether Lambrechts; Erik Storkebaum; Masafumi Morimoto; Jurgen Del-Favero; Frederik Desmet; Stefan L Marklund; Sabine Wyns; Vincent Thijs; Jörgen Andersson; Ingrid van Marion; Ammar Al-Chalabi; Stephanie Bornes; Rhiannon Musson; Valerie Hansen; Lars Beckman; Rolf Adolfsson; Hardev Singh Pall; Hervé Prats; Severine Vermeire; Paul Rutgeerts; Shigehiro Katayama; Takuya Awata; Nigel Leigh; Loïc Lang-Lazdunski; Mieke Dewerchin; Christopher Shaw; Lieve Moons; Robert Vlietinck; Karen E Morrison; Wim Robberecht; Christine Van Broeckhoven; Désiré Collen; Peter M Andersen; Peter Carmeliet
Journal:  Nat Genet       Date:  2003-08       Impact factor: 38.330

6.  Control of motoneuron survival by angiogenin.

Authors:  Dairín Kieran; Jordi Sebastia; Matthew J Greenway; Matthew A King; Dervla Connaughton; Caoimhin G Concannon; Beau Fenner; Orla Hardiman; Jochen H M Prehn
Journal:  J Neurosci       Date:  2008-12-24       Impact factor: 6.167

7.  A new role for angiogenin in neurite growth and pathfinding: implications for amyotrophic lateral sclerosis.

Authors:  Vasanta Subramanian; Ying Feng
Journal:  Hum Mol Genet       Date:  2007-04-27       Impact factor: 6.150

8.  TDP-43 mutation in familial amyotrophic lateral sclerosis.

Authors:  Akio Yokoseki; Atsushi Shiga; Chun-Feng Tan; Asako Tagawa; Hiroyuki Kaneko; Akihide Koyama; Hiroto Eguchi; Akira Tsujino; Takeshi Ikeuchi; Akiyoshi Kakita; Koichi Okamoto; Masatoyo Nishizawa; Hitoshi Takahashi; Osamu Onodera
Journal:  Ann Neurol       Date:  2008-04       Impact factor: 10.422

9.  A groupwise association test for rare mutations using a weighted sum statistic.

Authors:  Bo Eskerod Madsen; Sharon R Browning
Journal:  PLoS Genet       Date:  2009-02-13       Impact factor: 5.917

10.  SNCA variants are associated with increased risk for multiple system atrophy.

Authors:  Sonja W Scholz; Henry Houlden; Claudia Schulte; Manu Sharma; Abi Li; Daniela Berg; Anna Melchers; Reema Paudel; J Raphael Gibbs; Javier Simon-Sanchez; Coro Paisan-Ruiz; Jose Bras; Jinhui Ding; Honglei Chen; Bryan J Traynor; Sampath Arepalli; Ryan R Zonozi; Tamas Revesz; Janice Holton; Nick Wood; Andrew Lees; Wolfgang Oertel; Ullrich Wüllner; Stefano Goldwurm; Maria Teresa Pellecchia; Thomas Illig; Olaf Riess; Hubert H Fernandez; Ramon L Rodriguez; Michael S Okun; Werner Poewe; Gregor K Wenning; John A Hardy; Andrew B Singleton; Francesca Del Sorbo; Susanne Schneider; Kailash P Bhatia; Thomas Gasser
Journal:  Ann Neurol       Date:  2009-05       Impact factor: 10.422

View more
  82 in total

Review 1.  TDP-43 aggregation in neurodegeneration: are stress granules the key?

Authors:  Colleen M Dewey; Basar Cenik; Chantelle F Sephton; Brett A Johnson; Joachim Herz; Gang Yu
Journal:  Brain Res       Date:  2012-02-22       Impact factor: 3.252

Review 2.  Familial Amyotrophic Lateral Sclerosis.

Authors:  Kevin Boylan
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

3.  Angiogenin stimulates ribosomal RNA transcription by epigenetic activation of the ribosomal DNA promoter.

Authors:  Jinghao Sheng; Wenhao Yu; Xiangwei Gao; Zhengping Xu; Guo-Fu Hu
Journal:  J Cell Physiol       Date:  2014-04       Impact factor: 6.384

Review 4.  Clinical neurogenetics: amyotrophic lateral sclerosis.

Authors:  Matthew B Harms; Robert H Baloh
Journal:  Neurol Clin       Date:  2013-11       Impact factor: 3.806

5.  Transcription of angiogenin and ribonuclease 4 is regulated by RNA polymerase III elements and a CCCTC binding factor (CTCF)-dependent intragenic chromatin loop.

Authors:  Jinghao Sheng; Chi Luo; Yuxiang Jiang; Philip W Hinds; Zhengping Xu; Guo-fu Hu
Journal:  J Biol Chem       Date:  2014-03-21       Impact factor: 5.157

Review 6.  tRNA-derived fragments (tRFs): establishing their turf in post-transcriptional gene regulation.

Authors:  Srikar Krishna; Srikala Raghavan; Ramanuj DasGupta; Dasaradhi Palakodeti
Journal:  Cell Mol Life Sci       Date:  2021-01-02       Impact factor: 9.261

Review 7.  Transfer RNA-derived fragments and tRNA halves: biogenesis, biological functions and their roles in diseases.

Authors:  Yijing Shen; Xiuchong Yu; Linwen Zhu; Tianwen Li; Zhilong Yan; Junming Guo
Journal:  J Mol Med (Berl)       Date:  2018-09-19       Impact factor: 4.599

8.  Genome-wide identification and quantitative analysis of cleaved tRNA fragments induced by cellular stress.

Authors:  Mridusmita Saikia; Dawid Krokowski; Bo-Jhih Guan; Pavel Ivanov; Marc Parisien; Guo-fu Hu; Paul Anderson; Tao Pan; Maria Hatzoglou
Journal:  J Biol Chem       Date:  2012-10-19       Impact factor: 5.157

Review 9.  Lack of association between the Angiogenin (ANG) rs11701 polymorphism and amyotrophic lateral sclerosis risk: a meta-analysis.

Authors:  Li-Shou Pan; Xin-Bo Deng; Zheng Wang; Hui-Lin Leng; Xue-Peng Zhu; Dan Ding
Journal:  Neurol Sci       Date:  2016-01-11       Impact factor: 3.307

10.  Association between the Angiogenin (ANG) K17I variant and amyotrophic lateral sclerosis risk in Caucasian: a meta-analysis.

Authors:  Lishou Pan; Xinbo Deng; Dan Ding; Huilin Leng; Xuepeng Zhu; Zheng Wang
Journal:  Neurol Sci       Date:  2015-08-09       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.